BGJ398 (also known as BBP-831) ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
276	軟骨無形成症	3

276. 軟骨無形成症

臨床試験数 : 51 / 薬物数 : 34 - (DrugBank : 6) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 26

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001855-15-ES (EUCTR)	02/02/2022	15/09/2021	A study to evaluate long-term Infigratinib in children with Achondroplasia	Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosin ...	Achondroplasia in Children MedDRA version: 20.0;Level: LLT;Classification code 10000452;Term: Achond ...	Product Name: Infigratinib Product Code: BGJ398 (also known as BBP-831) INN or Proposed INN: INFIGRATI ...	QED Therapeutics, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 2	France;United States;Canada;Spain;Australia;United Kingdom
2	EUCTR2019-002954-21-FR (EUCTR)	06/05/2020	20/01/2020	A study to evaluate Infigratinib in children with Achondroplasia	Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study of Infigratinib, an FGFR 1-3-Selective ...	Achondroplasia in Children MedDRA version: 20.0;Level: LLT;Classification code 10000452;Term: Achond ...	Product Name: Infigratinib phosphate Product Code: BGJ398 (also known as BBP-831) INN or Proposed INN: ...	QED Therapeutics, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 2	United States;France;Canada;Spain;Australia;United Kingdom
3	EUCTR2019-002954-21-GB (EUCTR)	31/03/2020	13/05/2020	A study to evaluate Infigratinib in children with Achondroplasia	Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study of Infigratinib, an FGFR 1-3-Selective ...	Achondroplasia in Children MedDRA version: 20.0;Level: LLT;Classification code 10000452;Term: Achond ...	Product Name: Infigratinib phosphate Product Code: BGJ398 (also known as BBP-831) INN or Proposed INN: ...	QED Therapeutics, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	78	Phase 2	United States;France;Canada;Spain;Australia;United Kingdom

First Previous1Next Last